Vetter Pharma
Vetter Pharma, officially known as Vetter Pharma-Fertigung GmbH & Co. KG, is a leading global provider of aseptic filling and packaging services for the pharmaceutical and biotechnology industries. Headquartered in Ravensburg, Germany, the company operates extensively across Europe, North America, and Asia, catering to a diverse clientele. Founded in 1950, Vetter Pharma has achieved significant milestones, including the development of innovative delivery systems and a commitment to high-quality standards. The company specialises in prefilled syringes, vials, and cartridges, distinguished by their precision and reliability. Vetter's strong market position is underscored by its reputation for excellence and a robust portfolio of services that support drug development and commercialisation. With a focus on customer-centric solutions, Vetter Pharma continues to be a trusted partner in the evolving landscape of healthcare.
DitchCarbon Score
How does Vetter Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vetter Pharma's score of 29 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vetter Pharma's reported carbon emissions
In 2023, Vetter Pharma reported total carbon emissions of approximately 21,353,000 kg CO2e, with Scope 1 emissions accounting for about 17,852,000 kg CO2e and Scope 3 emissions contributing around 3,601,000 kg CO2e. Notably, their Scope 1 emissions included about 16,399,050 kg CO2e from stationary combustion and 34,400 kg CO2e from mobile combustion. The Scope 3 emissions primarily stemmed from business travel, waste generated in operations, and upstream transportation and distribution. In 2022, Vetter Pharma's emissions were approximately 30,000,000 kg CO2e, with Scope 1 emissions at about 18,000,000 kg CO2e and Scope 3 emissions reaching approximately 12,586,000 kg CO2e. The company has shown a commitment to reducing its carbon footprint, as indicated by its near-term targets, although it has not yet committed to a net-zero target. Vetter Pharma's emissions data reflects its ongoing efforts to address climate change within the pharmaceutical sector, which is increasingly focused on sustainability and reducing greenhouse gas emissions. The company is actively working towards its climate commitments, demonstrating a proactive approach to environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 19,683,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - |
| Scope 3 | 97,000 | 00,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vetter Pharma is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
